The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention
Authors
Keywords
-
Journal
Cells
Volume 10, Issue 1, Pages 142
Publisher
MDPI AG
Online
2021-01-13
DOI
10.3390/cells10010142
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- NF-κB-p62-NRF2 survival signaling is associated with high ROR1 expression in chronic lymphocytic leukemia
- (2020) Elsa Sanchez-Lopez et al. CELL DEATH AND DIFFERENTIATION
- E2F1‐Ror2 signaling mediates coordinated transcriptional regulation to promote G1/S phase transition in bFGF‐stimulated NIH/3T3 fibroblasts
- (2020) Mitsuharu Endo et al. FASEB JOURNAL
- ROR2 promotes the epithelial‐mesenchymal transition by regulating MAPK/p38 signaling pathway in breast cancer
- (2020) Jin Xu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- ROR1 regulates chemoresistance in Breast Cancer via modulation of drug efflux pump ABCB1
- (2020) Norman Fultang et al. Scientific Reports
- Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications
- (2020) Rebecca S. Goydel et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ROR2 suppresses metastasis of prostate cancer via regulation of miR-199a-5p–PIAS3–AKT2 signaling axis
- (2020) Jen-Chih Tseng et al. Cell Death & Disease
- ROR2 knockdown suppresses breast cancer growth through PI3K/ATK signaling
- (2020) Muhong Guo et al. Aging-US
- Canonical and non-canonical Wnt signaling are simultaneously activated by Wnts in colon cancer cells
- (2020) Eric Flores-Hernández et al. CELLULAR SIGNALLING
- Structural Insights into Pseudokinase Domains of Receptor Tyrosine Kinases
- (2020) Joshua B. Sheetz et al. MOLECULAR CELL
- Nuclear Regulation of Wnt/β-Catenin Signaling: It’s a Complex Situation
- (2020) Christin C. Anthony et al. Genes
- ROR1 is Expressed in Diffuse Large B-Cell Lymphoma (DLBCL) and a Small Molecule Inhibitor of ROR1 (KAN0441571C) Induced Apoptosis of Lymphoma Cells
- (2020) Amineh Ghaderi et al. Biomedicines
- Wnt5a enhances proliferation of chronic lymphocytic leukemia and ERK1/2 phosphorylation via a ROR1/DOCK2-dependent mechanism
- (2020) Md Kamrul Hasan et al. LEUKEMIA
- Glucocorticoids induce differentiation and chemoresistance in ovarian cancer by promoting ROR1-mediated stemness
- (2020) Hanna Karvonen et al. Cell Death & Disease
- ROR1 is upregulated in endometrial cancer and represents a novel therapeutic target
- (2020) Dongli Liu et al. Scientific Reports
- Wnt5a and ROR1 activate non-canonical Wnt signaling via RhoA in TCF3-PBX1 acute lymphoblastic leukemia and highlight new treatment strategies via Bcl-2 co-targeting
- (2019) Hanna Karvonen et al. ONCOGENE
- Inhibition of chemotherapy resistant breast cancer stem cells by a ROR1 specific antibody
- (2019) Suping Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ROR1 Expression and Its Functional Significance in Hepatocellular Carcinoma Cells
- (2019) Metin Cetin et al. Cells
- Chimeric Antigen Receptor T Cell Therapy for Solid Tumors: Current Status, Obstacles and Future Strategies
- (2019) Benjamin Heyman et al. Cancers
- Ovarian Cancer Stem Cells with High ROR1 Expression Serve as a New Prophylactic Vaccine for Ovarian Cancer
- (2019) Di Wu et al. Journal of Immunology Research
- ROR1-CAVIN3 interaction required for caveolae-dependent endocytosis and pro-survival signaling in lung adenocarcinoma
- (2019) Tomoya Yamaguchi et al. ONCOGENE
- Glucocorticoids promote breast cancer metastasis
- (2019) Milan M. S. Obradović et al. NATURE
- Logic-Gated ROR1 Chimeric Antigen Receptor Expression Rescues T Cell-Mediated Toxicity to Normal Tissues and Enables Selective Tumor Targeting
- (2019) Shivani Srivastava et al. CANCER CELL
- Novel ROR1 Inhibitor ARI-1 Suppresses the Development of Non-Small Cell Lung Cancer
- (2019) Xuesha Liu et al. CANCER LETTERS
- Wnt5a induces ROR1 and ROR2 to activate RhoA in esophageal squamous cell carcinoma cells
- (2019) Xuping Wu et al. Cancer Management and Research
- Antibody-drug conjugate T-DM1 treatment for HER2+ breast cancer induces ROR1 and confers resistance through activation of Hippo transcriptional coactivator YAP1
- (2019) Syed S. Islam et al. EBioMedicine
- Src and Fyn define a new signaling cascade activated by canonical and non-canonical Wnt ligands and required for gene transcription and cell invasion
- (2019) Aida Villarroel et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma
- (2019) Fernanda Faião-Flores et al. CLINICAL CANCER RESEARCH
- The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation
- (2019) M. Frenquelli et al. LEUKEMIA
- Strictinin, a novel ROR1-inhibitor, represses triple negative breast cancer survival and migration via modulation of PI3K/AKT/GSK3ß activity
- (2019) Norman Fultang et al. PLoS One
- Blocking ROR1 enhances the roles of erlotinib in lung adenocarcinoma cell lines
- (2019) Hui‑Li Wang et al. Oncology Letters
- Cirmtuzumab blocks Wnt5a/ROR1 stimulation of NF-κB to repress autocrine STAT3 activation in chronic lymphocytic leukemia
- (2019) Yun Chen et al. BLOOD
- Cutting Edge: ROR1/CD19 Receptor Complex Promotes Growth of Mantle Cell Lymphoma Cells Independently of the B Cell Receptor–BTK Signaling Pathway
- (2019) Qian Zhang et al. JOURNAL OF IMMUNOLOGY
- ROR1 and ROR2—novel targets for neuroblastoma
- (2019) Hema Dave et al. PEDIATRIC HEMATOLOGY AND ONCOLOGY
- Molecular Mechanisms Associated with ROR1-Mediated Drug Resistance: Crosstalk with Hippo-YAP/TAZ and BMI-1 Pathways
- (2019) Hanna Karvonen et al. Cells
- Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process
- (2019) Mostafa Karimi Roshan et al. BIOCHIMIE
- Vls-101 Is a Novel Therapeutic Antibody-Drug Conjugate (ADC) Targeting Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) in Richter's Syndrome (RS)
- (2019) Tiziana Vaisitti et al. BLOOD
- Wnt Signaling in the Regulation of Immune Cell and Cancer Therapeutics
- (2019) Haseeb et al. Cells
- ROR2 induces cell apoptosis via activating IRE1α/JNK/CHOP pathway in high-grade serous ovarian carcinoma in vitro and in vivo
- (2019) Rui Li et al. Journal of Translational Medicine
- Wnt5a induces ROR1 to recruit DOCK2 to activate Rac1/2 in chronic lymphocytic leukemia
- (2018) Md Kamrul Hasan et al. BLOOD
- Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic Leukemia
- (2018) Michael Y. Choi et al. Cell Stem Cell
- Dishevelled: A masterful conductor of complex Wnt signals
- (2018) Monica Sharma et al. CELLULAR SIGNALLING
- Critical role of the Ror-family of receptor tyrosine kinases in invasion and proliferation of malignant pleural mesothelioma cells
- (2018) Takeshi Saji et al. GENES TO CELLS
- ROR1 and ROR2 play distinct and opposing roles in endometrial cancer
- (2018) C.E. Henry et al. GYNECOLOGIC ONCOLOGY
- First-in-class oral small molecule inhibitor of the tyrosine kinase ROR1 (KAN0439834) induced significant apoptosis of chronic lymphocytic leukemia cells
- (2018) M. Hojjat-Farsangi et al. LEUKEMIA
- CK1ε and p120-catenin control Ror2 function in noncanonical Wnt signaling
- (2018) Josué Curto et al. Molecular Oncology
- A receptor tyrosine kinase ROR1 inhibitor (KAN0439834) induced significant apoptosis of pancreatic cells which was enhanced by erlotinib and ibrutinib
- (2018) Amir Hossein Daneshmanesh et al. PLoS One
- Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1
- (2018) Junpeng Qi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CAR T cell immunotherapy for human cancer
- (2018) Carl H. June et al. SCIENCE
- β-catenin-independent regulation of Wnt target genes by RoR2 and ATF2/ATF4 in colon cancer cells
- (2018) Oksana Voloshanenko et al. Scientific Reports
- Twist promotes tumor metastasis in basal-like breast cancer by transcriptionally upregulating ROR1
- (2018) Jingying Cao et al. Theranostics
- Abstract 833: Anti-tumor efficacy of BA3021, a novel Conditionally Active Biologic (CAB) anti-ROR2 ADC
- (2018) Leslie L. Sharp et al. CANCER RESEARCH
- ROR1 is highly expressed in circulating tumor cells and promotes invasion of pancreatic cancer
- (2018) Gui‑Li Xu et al. Molecular Medicine Reports
- Expression Analysis of Platinum Sensitive and Resistant Epithelial Ovarian Cancer Patient Samples Reveals New Candidates for Targeted Therapies
- (2018) K Veskimäe et al. Translational Oncology
- Wnt/PCP controls spreading of Wnt/β-catenin signals by cytonemes in vertebrates
- (2018) Benjamin Mattes et al. eLife
- Novel Antibody Drug Conjugates Targeting Tumor-Associated Receptor Tyrosine Kinase ROR2 by Functional Screening of Fully Human Antibody Libraries Using Transpo-mAb Display on Progenitor B Cells
- (2018) Ina Hellmann et al. Frontiers in Immunology
- FOXO Signaling Pathways as Therapeutic Targets in Cancer
- (2017) Mohd Farhan et al. International Journal of Biological Sciences
- Adipocytes sustain pancreatic cancer progression through a non-canonical WNT paracrine network inducing ROR2 nuclear shuttling
- (2017) C Carbone et al. INTERNATIONAL JOURNAL OF OBESITY
- The Ror1 receptor tyrosine kinase plays a critical role in regulating satellite cell proliferation during regeneration of injured muscle
- (2017) Koki Kamizaki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Mining Naïve Rabbit Antibody Repertoires by Phage Display for Monoclonal Antibodies of Therapeutic Utility
- (2017) Haiyong Peng et al. JOURNAL OF MOLECULAR BIOLOGY
- Wnt5a induces ROR1 to associate with 14-3-3ζ for enhanced chemotaxis and proliferation of chronic lymphocytic leukemia cells
- (2017) J Yu et al. LEUKEMIA
- Wnt5a induces ROR1 to complex with HS1 to enhance migration of chronic lymphocytic leukemia cells
- (2017) M K Hasan et al. LEUKEMIA
- Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression
- (2017) K Roarty et al. ONCOGENE
- Ror2, a Developmentally Regulated Kinase, Is Associated With Tumor Growth, Apoptosis, Migration, and Invasion in Renal Cell Carcinoma
- (2017) Chun-ming Yang et al. ONCOLOGY RESEARCH
- Distinct Patterns of Stromal and Tumor Expression of ROR1 and ROR2 in Histological Subtypes of Epithelial Ovarian Cancer
- (2017) C.E. Henry et al. Translational Oncology
- Ectopic repression of receptor tyrosine kinase–like orphan receptor 2 inhibits malignant transformation of ovarian cancer cells by reversing epithelial–mesenchymal transition
- (2017) Ying Xu et al. TUMOR BIOLOGY
- ROR1 expression as a biomarker for predicting prognosis in patients with colorectal cancer
- (2017) Jian-Kang Zhou et al. Oncotarget
- Kinesin superfamily protein Kif26b links Wnt5a-Ror signaling to the control of cell and tissue behaviors in vertebrates
- (2017) Michael W Susman et al. eLife
- An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors
- (2017) Satyen Harish Gohil et al. OncoImmunology
- Ror2 Signaling and Its Relevance in Breast Cancer Progression
- (2017) Michaela Bayerlová et al. Frontiers in Oncology
- Ror2 signaling regulates Golgi structure and transport through IFT20 for tumor invasiveness
- (2017) Michiru Nishita et al. Scientific Reports
- High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia
- (2016) B. Cui et al. BLOOD
- ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration
- (2016) Sean S. Q. Ma et al. BMC CANCER
- Receptor tyrosine kinase-like orphan receptor 1, a target ofNKX2-1/TTF-1lineage-survival oncogene, inhibits apoptosis signal-regulating kinase 1-mediated pro-apoptotic signaling in lung adenocarcinoma
- (2016) Lisa Ida et al. CANCER SCIENCE
- Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells
- (2016) Eun-Hwa Jung et al. CELL BIOCHEMISTRY AND FUNCTION
- WNT5A–ROR2 is induced by inflammatory mediators and is involved in the migration of human ovarian cancer cell line SKOV-3
- (2016) Somayeh Arabzadeh et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- β-catenin-independent WNT signaling and Ki67 in contrast to the estrogen receptor status are prognostic and associated with poor prognosis in breast cancer liver metastases
- (2016) Annalen Bleckmann et al. CLINICAL & EXPERIMENTAL METASTASIS
- Analysis of ROR1 Protein Expression in Human Cancer and Normal Tissues
- (2016) Ashwini Balakrishnan et al. CLINICAL CANCER RESEARCH
- Critical role of Ror2 receptor tyrosine kinase in regulating cell cycle progression of reactive astrocytes following brain injury
- (2016) Mitsuharu Endo et al. GLIA
- Cirmtuzumab inhibits Wnt5a-induced Rac1 activation in chronic lymphocytic leukemia treated with ibrutinib
- (2016) J Yu et al. LEUKEMIA
- Validation of specificity of antibodies for immunohistochemistry: the case of ROR2
- (2016) Sean S.Q. Ma et al. VIRCHOWS ARCHIV
- Expression of ROR1 has prognostic significance in triple negative breast cancer
- (2016) Hui-Ping Chien et al. VIRCHOWS ARCHIV
- ROR2 inhibits the proliferation of gastric carcinoma cells via activation of non-canonical Wnt signaling
- (2016) Likun Yan et al. Experimental and Therapeutic Medicine
- ROR1 sustains caveolae and survival signalling as a scaffold of cavin-1 and caveolin-1
- (2016) Tomoya Yamaguchi et al. Nature Communications
- Migration and invasion is inhibited by silencing ROR1 and ROR2 in chemoresistant ovarian cancer
- (2016) C E Henry et al. Oncogenesis
- 14-3-3β Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells by Modulating Expression of MMP2 and MMP9 through PI3K/Akt/NF-κB Pathway
- (2016) Yufu Tang et al. PLoS One
- ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma
- (2016) Yu-Zhu Zheng et al. Scientific Reports
- Expression of ROR1, pAkt, and pCREB in gastric adenocarcinoma
- (2015) Hyeyoon Chang et al. Annals of Diagnostic Pathology
- Wnt-Frizzled/Planar Cell Polarity Signaling: Cellular Orientation by Facing the Wind (Wnt)
- (2015) Yingzi Yang et al. Annual Review of Cell and Developmental Biology
- Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia
- (2015) P. Janovska et al. CLINICAL CANCER RESEARCH
- Pre-clinical Specificity and Safety of UC-961, a First-In-Class Monoclonal Antibody Targeting ROR1
- (2015) Michael Y. Choi et al. Clinical Lymphoma Myeloma & Leukemia
- The PTK7 and ROR2 Protein Receptors Interact in the Vertebrate WNT/Planar Cell Polarity (PCP) Pathway
- (2015) Sébastien Martinez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation
- (2015) Jian Yu et al. JOURNAL OF CLINICAL INVESTIGATION
- miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer
- (2015) Jinqiu Tao et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- ROR1 contributes to melanoma cell growth and migration by regulating N-cadherin expression via the PI3K/Akt pathway
- (2015) Natalia Brenda Fernández et al. MOLECULAR CARCINOGENESIS
- Receptor tyrosine kinase gene expression profiles of Ewing sarcomas reveal ROR1 as a potential therapeutic target in metastatic disease
- (2015) Jenny Potratz et al. Molecular Oncology
- Wnt5a, Ryk and Ror2 expression in glioblastoma subgroups
- (2015) Yuil Kim et al. PATHOLOGY RESEARCH AND PRACTICE
- Newly Constructed Network Models of Different WNT Signaling Cascades Applied to Breast Cancer Expression Data
- (2015) Michaela Bayerlová et al. PLoS One
- Knockdown of receptor tyrosine kinase-like orphan receptor 2 inhibits cell proliferation and colony formation in osteosarcoma cells by inducing arrest in cell cycle progression
- (2015) JIANJUN HUANG et al. Oncology Letters
- Over-expression of ROR2 and Wnt5a cooperatively correlates with unfavorable prognosis in patients with non-small cell lung cancer
- (2015) Chenlin Lu et al. Oncotarget
- Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion
- (2015) Claire Henry et al. Oncotarget
- High ROR2 expression in tumor cells and stroma is correlated with poor prognosis in pancreatic ductal adenocarcinoma
- (2015) Jianfei Huang et al. Scientific Reports
- Are BiTEs the “missing link” in cancer therapy?
- (2015) Carter M Suryadevara et al. OncoImmunology
- Silencing of Receptor Tyrosine Kinase ROR1 Inhibits Tumor-Cell Proliferation via PI3K/AKT/mTOR Signaling Pathway in Lung Adenocarcinoma
- (2015) Yanchun Liu et al. PLoS One
- IGF1R- and ROR1-Specific CAR T Cells as a Potential Therapy for High Risk Sarcomas
- (2015) Xin Huang et al. PLoS One
- High expression of ROR2 in cancer cell correlates with unfavorable prognosis in colorectal cancer
- (2014) Haijun Mei et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The PI3K/AKT/mTOR pathway is involved in direct apoptosis of CLL cells induced by ROR1 monoclonal antibodies
- (2014) Amir Hossein Daneshmanesh et al. BRITISH JOURNAL OF HAEMATOLOGY
- The ROR1 pseudokinase diversifies signaling outputs in MET-addicted cancer cells
- (2014) Alessandra Gentile et al. INTERNATIONAL JOURNAL OF CANCER
- Expression of the novel Wnt receptor ROR2 is increased in breast cancer and may regulate both β-catenin dependent and independent Wnt signalling
- (2014) C. Henry et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Selective Antitumor Activity of Ibrutinib in EGFR-Mutant Non–Small Cell Lung Cancer Cells
- (2014) Wen Gao et al. JNCI-Journal of the National Cancer Institute
- Interleukin-1 -Induced Wnt5a Enhances Human Corneal Endothelial Cell Migration through Regulation of Cdc42 and RhoA
- (2014) J. G. Lee et al. MOLECULAR AND CELLULAR BIOLOGY
- Evolutionary Divergence in the Catalytic Activity of the CAM-1, ROR1 and ROR2 Kinase Domains
- (2014) Travis W. Bainbridge et al. PLoS One
- Ovarian cancer stem cells express ROR1, which can be targeted for anti–cancer-stem-cell therapy
- (2014) Suping Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- ROR1 expression correlated with poor clinical outcome in human ovarian cancer
- (2014) Huilin Zhang et al. Scientific Reports
- Safety of Targeting ROR1 in Primates with Chimeric Antigen Receptor-Modified T Cells
- (2014) C. Berger et al. Cancer Immunology Research
- The Planar Cell Polarity Pathway Drives Pathogenesis of Chronic Lymphocytic Leukemia by the Regulation of B-Lymphocyte Migration
- (2013) M. Kaucka et al. CANCER RESEARCH
- Targeting ROR1 Inhibits Epithelial-Mesenchymal Transition and Metastasis
- (2013) B. Cui et al. CANCER RESEARCH
- Receptor Tyrosine Kinase-like Orphan Receptor 2 (Ror2) Expression Creates a Poised State of Wnt Signaling in Renal Cancer
- (2013) Neal R. Rasmussen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Inhibition of the Receptor Tyrosine Kinase ROR1 by Anti-ROR1 Monoclonal Antibodies and siRNA Induced Apoptosis of Melanoma Cells
- (2013) Mohammad Hojjat-Farsangi et al. PLoS One
- ROR1 can interact with TCL1 and enhance leukemogenesis in E -TCL1 transgenic mice
- (2013) G. F. Widhopf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hypoxia Induces Phenotypic Plasticity and Therapy Resistance in Melanoma via the Tyrosine Kinase Receptors ROR1 and ROR2
- (2013) M. P. O'Connell et al. Cancer Discovery
- The Onco-Embryonic Antigen ROR1 Is Expressed by a Variety of Human Cancers
- (2012) Suping Zhang et al. AMERICAN JOURNAL OF PATHOLOGY
- Crosstalk between ROR1 and the Pre-B Cell Receptor Promotes Survival of t(1;19) Acute Lymphoblastic Leukemia
- (2012) Vincent T. Bicocca et al. CANCER CELL
- NKX2-1/TITF1/TTF-1-Induced ROR1 Is Required to Sustain EGFR Survival Signaling in Lung Adenocarcinoma
- (2012) Tomoya Yamaguchi et al. CANCER CELL
- The dual role of the novel Wnt receptor tyrosine kinase, ROR2, in human carcinogenesis
- (2012) Caroline E. Ford et al. INTERNATIONAL JOURNAL OF CANCER
- ROR2 is a novel prognostic biomarker and a potential therapeutic target in leiomyosarcoma and gastrointestinal stromal tumour
- (2012) Badreddin Edris et al. JOURNAL OF PATHOLOGY
- Orphan receptor tyrosine kinases ROR1 and ROR2 in hematological malignancies
- (2012) Amir Hossein Daneshmanesh et al. LEUKEMIA & LYMPHOMA
- ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth
- (2012) Suping Zhang et al. PLoS One
- Dvl2-Dependent Activation of Daam1 and RhoA Regulates Wnt5a-Induced Breast Cancer Cell Migration
- (2012) Yichao Zhu et al. PLoS One
- Restricted Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Pediatric B-Lineage Acute Lymphoblastic Leukemia Suggests Targetability with Therapeutic Monoclonal Antibodies
- (2012) Hema Dave et al. PLoS One
- Post-translational modifications regulate signalling by Ror1
- (2011) M. Kaucká et al. Acta Physiologica
- Ror1 Is a Pseudokinase That Is Crucial for Met-Driven Tumorigenesis
- (2011) A. Gentile et al. CANCER RESEARCH
- Critical role of Wnt5a-Ror2 signaling in motility and invasiveness of carcinoma cells following Snail-mediated epithelial-mesenchymal transition
- (2011) Dayong Ren et al. GENES TO CELLS
- ROR1 is expressed on hematogones (non-neoplastic human B-lymphocyte precursors) and a minority of precursor-B acute lymphoblastic leukemia
- (2011) H. Elizabeth Broome et al. LEUKEMIA RESEARCH
- Overexpression of 14-3-3ζ in cancer cells activates PI3K via binding the p85 regulatory subunit
- (2011) C L Neal et al. ONCOGENE
- The B-cell tumor-associated antigen ROR1 can be targeted with T cells modified to express a ROR1-specific chimeric antigen receptor
- (2010) M. Hudecek et al. BLOOD
- Nuclear localization of orphan receptor protein kinase (Ror1) is mediated through the juxtamembrane domain
- (2010) Hsiao-Chun Tseng et al. BMC CELL BIOLOGY
- β-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis
- (2010) F. Klemm et al. CARCINOGENESIS
- Negative regulation of Wnt signaling mediated by CK1-phosphorylated Dishevelled via Ror2
- (2010) Florian Witte et al. FASEB JOURNAL
- Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors
- (2010) L. Grumolato et al. GENES & DEVELOPMENT
- ROR1 expression is not a unique marker of CLL
- (2010) Gábor Barna et al. HEMATOLOGICAL ONCOLOGY
- The Wnt5a/Ror2 noncanonical signaling pathway inhibits canonical Wnt signaling in K562 cells
- (2010) Wei Si INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Ror2/Frizzled Complex Mediates Wnt5a-Induced AP-1 Activation by Regulating Dishevelled Polymerization
- (2010) M. Nishita et al. MOLECULAR AND CELLULAR BIOLOGY
- Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer
- (2010) Ester Lara et al. Molecular Cancer
- Wnt5a signaling is involved in the aggressiveness of prostate cancer and expression of metalloproteinase
- (2010) H Yamamoto et al. ONCOGENE
- Stat3 Activates the Receptor Tyrosine Kinase Like Orphan Receptor-1 Gene in Chronic Lymphocytic Leukemia Cells
- (2010) Ping Li et al. PLoS One
- Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma
- (2009) Kazuhito Morioka et al. CANCER SCIENCE
- Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling
- (2009) Amanda Mikels et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling
- (2009) M Enomoto et al. ONCOGENE
- Ror2, a developmentally regulated kinase, promotes tumor growth potential in renal cell carcinoma
- (2009) T M Wright et al. ONCOGENE
- The orphan tyrosine kinase receptor, ROR2, mediates Wnt5A signaling in metastatic melanoma
- (2009) M P O’Connell et al. ONCOGENE
- Ror2 modulates the canonical Wnt signaling in lung epithelial cells through cooperation with Fzd2
- (2008) Changgong Li et al. BMC MOLECULAR BIOLOGY
- Unique Cell Surface Expression of Receptor Tyrosine Kinase ROR1 in Human B-Cell Chronic Lymphocytic Leukemia
- (2008) S. Baskar et al. CLINICAL CANCER RESEARCH
- Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy
- (2008) Amir H. DaneshManesh et al. INTERNATIONAL JOURNAL OF CANCER
- Receptor Tyrosine Kinase Ror2 Mediates Wnt5a-induced Polarized Cell Migration by Activating c-Jun N-terminal Kinase via Actin-binding Protein Filamin A
- (2008) Akira Nomachi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Deleted in Brachydactyly B Domain of ROR2 Is Required for Receptor Activation by Recruitment of Src
- (2008) Shiva Akbarzadeh et al. PLoS One
- Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a
- (2008) T. Fukuda et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More